Use of Prednisone With Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer
Use of Prednisone With Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Use of Prednisone With Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer have?
Use of Prednisone With Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer has 109 citations in the OpenAlex counts ScholarIQ stores.
When was Use of Prednisone With Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer published?
Use of Prednisone With Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer has 2014 year in the ScholarIQ index.
What is the open-access status of Use of Prednisone With Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer?
Use of Prednisone With Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer has bronze oa status in the ScholarIQ index.
What is the DOI of Use of Prednisone With Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer?
The DOI for Use of Prednisone With Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer is on the source record.
What is the PMID of Use of Prednisone With Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer?
The PMID for Use of Prednisone With Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer is on the source record.
What is the OpenAlex record for Use of Prednisone With Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer?
The OpenAlex for Use of Prednisone With Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer is on the source record.